Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

3

Other

2

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Dopamine receptor

3

Secretion of bile

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

4

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1974

3

Unknown

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hemodynamic imbalances present in the shock syndrome

3

Bile duct disease

1

Chronic liver disease

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

4

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

3

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Waser, E.|Sommer, H.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

6

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

6

ECHA (EC/EINECS)

6

EPA CompTox

6

FDA UNII

6

PUBCHEM

6

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

CARDIOVASCULAR SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

CARDIAC THERAPY

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Adrenergic and dopaminergic agents

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

4

Salts, Hydrates, Esters, etc.

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 6 of 6 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DOPAMINE

VTD58H1Z2X

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1974

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Dopamine receptor

Conditions:

Hemodynamic imbalances present in the shock syndrome

Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotr...

ansmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Dopamine HCl is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure.

1-PHENYL-2-PENTANONE

36VW7X5C4P

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

5-PHENYLPENTANOL

63AX6O7ZXD

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

FENIPENTOL

X3FZE77O60

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Secretion of bile

Conditions:

Bile duct disease

Chronic liver disease

Fenipentol is a choleretic agent indicated for the treatment of chronic liver disease and bile duct disease. The drug is sold without prescription.

Dopamine hydrobromide

MT86RG32QV

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1974

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Dopamine receptor

Conditions:

Hemodynamic imbalances present in the shock syndrome

Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotr...

ansmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Dopamine HCl is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure.

DOPAMINE HYDROCHLORIDE

7L3E358N9L

Export Data
Search for Structure

Status:

US Approved Rx (2018)

First approved in 1974

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Dopamine receptor

Conditions:

Hemodynamic imbalances present in the shock syndrome

Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotr...

ansmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Dopamine HCl is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1